|
|
Volumn 351, Issue 6, 2004, Pages
|
|
The antibiotic pipeline - Challenges, costs, and values
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
CHLORAMPHENICOL;
DAPTOMYCIN;
GLYCOPEPTIDE;
IMIPENEM;
LINEZOLID;
LIPOPEPTIDE;
MACROLIDE;
METICILLIN;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMYCIN;
SULFONAMIDE;
TETRACYCLINE;
TRIMETHOPRIM;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTEREMIA;
BACTERIAL INFECTION;
DRUG COST;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ENTEROCOCCUS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MORTALITY;
PRIORITY JOURNAL;
REVIEW;
STAPHYLOCOCCUS AUREUS;
ANIMAL;
ARTICLE;
CHEMISTRY;
ECONOMICS;
HISTORY;
HUMAN;
MEDICAL RESEARCH;
UNITED STATES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BIOMEDICAL RESEARCH;
CHEMISTRY, PHARMACEUTICAL;
DRUG COSTS;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
UNITED STATES;
|
|
EID: 3442887705
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp048093 Document Type: Review |
|
Times cited : (193)
|
|
References (5)
|
